Patents by Inventor Clifford D. Bedford

Clifford D. Bedford has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5352829
    Abstract: Energetic nitramine containing cyclotriphosphazene which include 1,1,3,3,-tris-spiro(N,N'-dinitroethylenediamino)cyclotriphosphazene, 1,1-spiro(ethylenediamino)-3,3,5,5-bis-spiro(N,N'-dinitroethylenediamino)c yclotriphosphazene, 1,1,3,3-bis-spiro(N,N'-dinitroethylenediamino)-5,5-dichlorocyclotriphospha zene, 1,1,3,3-bis-spiro(N,N'-dinitroethylenediamino)-5,5-difluorocyclotriphospha zene, 1,1-spiro(N,N'-dinitroethylenediamino)-3,3,5,5-bis-spiro(ethylenediamino)c yclotriphosphazene, 1,1-spiro(ethylenediamino)-3,3-spiro(N,N'-dinitroethylenediamino)-5,5-dich lorocyclotriphosphazene, 1,1-spiro(ethylenediamino)-3,3-spiro(N,N'-dinitroethylenediamino)-5,5-difl uorocyclotriphosphazene, 1,1-spiro(N,N'-dinitroethylenediamino)-3,3,5,5-tetrachlorocyclotriphosphaz ene, and 1,1-spiro(N,N'-dinitroethylenediamino)-3,3,5,5-tetrafluorocyclotriphosphaz ene, which can be used in explosive compositions.
    Type: Grant
    Filed: April 2, 1993
    Date of Patent: October 4, 1994
    Assignee: The United States of America as represented by the Secretary of the Navy
    Inventors: Paritosh R. Dave, Farhad Forohar, Michael Chaykovsky, Clifford D. Bedford
  • Patent number: 4925856
    Abstract: A therapeutically effective class of low toxicity aldoxime-substituted functionalized imidazolium compounds and compositions is disclosed which is effective in the treatment of living species poisoned by organophosphorus chemicals which inactivate the enzyme acetylcholinesterase. In vivo administration of therapeutically effective amounts of these aldoxime-substituted imidazolium derivatives has been found to save mammals having inhibited acetylcholinesterase due to injection with lethal dosages of Soman.
    Type: Grant
    Filed: April 19, 1989
    Date of Patent: May 15, 1990
    Assignee: SRI International
    Inventors: Ralph N. Harris, III, Clifford D. Bedford, Dane A. Goff, Duane E. Hilmas, Robert A. Howd, Richard A. Kenley, Gary A. Koolpe, Robert O. Pick
  • Patent number: 4865837
    Abstract: A therapeutically effective class of low toxicity aldoxime-substituted trazolium derivatives is disclosed which is effective in the treatment of living species poisoned by organophosphorus chemicals which inactivate the enzyme acetylcholinesterase. In vivo administration of therapeutically effective amounts of these low toxicity aldoxime-substituted triazolium derivatives has been found to save mice having inhibited acetylcholinesterase due to injection with lethal dosages of Soman.
    Type: Grant
    Filed: July 28, 1987
    Date of Patent: September 12, 1989
    Assignee: SRI International
    Inventors: Ralph N. Harris, III, Clifford D. Bedford, Duane E. Hilmas, Robert A. Howd, Richard A. Kenley, Gary A. Koolpe
  • Patent number: 4618734
    Abstract: A perfluoroalkylene .alpha.,.omega.-diacetylene compound having a fluorocarbon chain of from 5 to about 20 carbon atoms between two acetylene end groups, and a method of forming same by first reacting perfluoroalkylene diiodide having the formula I(CF.sub.2).sub.n I, wherein n is a whole number from 5 to about 20, inclusive with bis(trimethylsilyl)acetylene, and converting the reaction product to the diacetylene with KF. The diacetylene has the general formula HC.tbd.C(CF.sub.2).sub.n C.tbd.CH, wherein n is as set forth above, and it can be polymerized to produce a clear, hard, cross-linked resin suitable for use as a coating on bearings and in the manufacture of aircraft windshields. Monofunctional counterparts of the HC.tbd.C(CF.sub.2).sub.n C.tbd.CH compounds can be formed by substituting perfluoroalkyl primary iodides for the diiodides in the above-described reaction.
    Type: Grant
    Filed: August 12, 1983
    Date of Patent: October 21, 1986
    Assignee: Fluorochem Inc.
    Inventors: Kurt Baum, Ronald O. Hunadi, Clifford D. Bedford
  • Patent number: 4347376
    Abstract: A perfluoroalkylene .alpha.,.omega.-diacetylene compound having a fluorocarbon chain of from 5 to about 20 carbon atoms between two acetylene end groups, and a method of forming same by first carrying out the addition reaction of a perfluoroalkylene diiodide having the formula I(CF.sub.2).sub.n I, where n is a whole number from 5 to about 20, inclusive, and trimethylsilyacetylene in the presence of a free radical catalyst to form (CH.sub.3).sub.3 SiIC.dbd.CH(CH.sub.2).sub.n CH.dbd.CISi(CH.sub.3).sub.3 ; subjecting the (CH.sub.3).sub.3 SiIC.dbd.CH(CF.sub.2).sub.n CH.dbd.CISi(CH.sub.3).sub.3 to dehydrohalogenation with DBU under dry conditions to obtain (CH.sub.3).sub.3 SiC.tbd.C(CF.sub.2).sub.n C .tbd.CSi(CH.sub.3).sub.3 ; and removing the silyl group from the latter compound with excess DBU or KF to yield HC.tbd.C(CF.sub.2).sub.n C.tbd.CH as the perfluoroalkylene .alpha.,.omega.-diacetylene compound. The HC.tbd.C(CF.sub.2).sub.n C.tbd.
    Type: Grant
    Filed: December 24, 1980
    Date of Patent: August 31, 1982
    Assignee: Fluorchem Inc.
    Inventors: Kurt Baum, Clifford D. Bedford, Ronald O. Hunadi
  • Patent number: 4346222
    Abstract: 1,3,5,5-Tetranitrohexahydropyrimidine, termed DNNC for convenience, useful as an oxident in explosive and rocket propellant compositions.
    Type: Grant
    Filed: December 4, 1980
    Date of Patent: August 24, 1982
    Assignee: SRI International
    Inventors: Donald A. Levins, Clifford D. Bedford, Clifford L. Coon
  • Patent number: 4220804
    Abstract: Substituted gem-dinitroalkanes are prepared by reacting a nitro olefin, tetranitromethane and an alcohol or organolithium derivative. The substituted gem-dinitroalkanes are useful as explosives, plasticizers and binders.
    Type: Grant
    Filed: November 20, 1978
    Date of Patent: September 2, 1980
    Assignee: The United States of America as represented by the Secretary of the Navy
    Inventors: Arnold T. Nielsen, Clifford D. Bedford